ZC3H12A and psoriasis: Regnase-1 has been broadly investigated in a great many diseases to exemplify its immunomodulatory capabilities in animal models, including rheumatoid arthritis, psoriasis, cardiovascular disorders, and cancer (Skalniak et al., 2018).